271 Development of OR2805, an anti-CD163 antibody derived from an elite responder to checkpoint inhibitor therapy that relieves immunosuppression caused by M2c macrophages
oleh: Peter Probst, Huyen Dinh, Sam Lam, Valerie Wall, Darbie Whitman, Tom Graddis, Myriam Bouchlaka, Randi Simmons, Meghan Zuck, Ray Fox, Kamal Puri
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.